Nachrichten zur Pacific Biosciences of California Aktie

Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 11.11% and 10.58%, respectively, for the quarter ended June 2019. Do…

What Happens If Pacific Biosciences Isnt Acquired By Illumina-

Abandoning the proposed deal would have a seismic effect on the future of DNA sequencing, but its not all bad…

Why J.C. Penney, QEP Resources, and Pacific Biosciences Slumped Today

Bad news on several different fronts held these stocks back....…

Heres Why Pacific Biosciences Is Tumbling Today

Trade investigations and a stumbling patent portfolio have investors growing anxious about the pending acquisition by Illumina....…

UKs CMA refers Illumina-Pacific Biosciences deal for in-depth investigation

Britains competition watchdog said on Thursday it would launch an in-depth investigation into the planned $1.2 billion merger between gene sequencing company Illumina…

The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health

The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health...…

Pacific Biosciences Stumbles As The U.K. Raises Concerns About Illuminas Bid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-UKs CMA says Illumina-Pacific Biosciences deal could hurt competition

Britains competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of…

UKs CMA says Illumina-Pacific Biosciences deal could hurt competition

Britains competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of…

Pacific Biosciences (PACB) Down 7.8% Since Last Earnings Report: Can It Rebound-

Pacific Biosciences (PACB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Pacific Biosciences (PACB) Incurs Loss in Q1, Revenues Fall

Pacific Biosciences (PACB) segments see softness in Q1; merger with Illumina on track....…

Pump the Brakes on the Illumina and Pacific Biosciences Deal

The United Kingdoms Competition and Markets Authority has opened an investigation into the acquisition. What happens now?...…

Pacific Biosciences (PACB) Up 3.8% Since Last Earnings Report: Can It Continue-

Pacific Biosciences (PACB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Pacific Biosciences of California (PACB) Reports Q4 Loss, Lags Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -61.54% and -7.37%, respectively, for the quarter ended December 2018. Do…

Heres Why You Should Hold Pacific Biosciences (PACB) Now

Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat…

Pacific Biosciences Offers Insights on Aedes aegypti Genome

Pacific Biosciences (PACB) uses its flagship Single Molecule, Real-Time technology to sequence the highest quality genome assembly for the Aedes…

Is This the Real Reason Illumina Acquired Pacific Biosciences-

The $1.2 billion acquisition will combine the two leading DNA sequencing technology platforms, but the battle for the future of…

Why Alkermes Depression Drug Stumbled, and How Illumina Plans to Profit From M&A

Heres what derailed the drug, and why Illumina is paying $1.2 billion to acquire Pacific Biosciences....…

Pacific Biosciences (PACB) Reports Q3 Loss, Revenues Fall Y/Y

Pacific Biosciences (PACB) is getting acquired by Illumina (ILMN) by mid-2019....…

Illumina (ILMN) Inks $1.2B Deal to Buy Pacific Biosciences

Illumina (ILMN) taking out on its peer, in the $1.2-billion acquisition deal, will further strengthen the position of the former…

Illumina, Inc. (ILMN) CEO Francis deSouza Hosts Acquisition of Pacific Biosciences Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heres Why Illimuna Just Bought Its Biggest Competitor

Illumina surprised investors this week by announcing its buying Pacific Biosciences. Heres how the deal could move the needle for…

Why Newell Brands, VeriSign, and Pacific Biosciences of California Jumped Today

Find out which of these stocks got a buyout bid....…

Pacific Biosciences Bows Out Gracefully

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mid-Day Market Update: Dow Down 100 Points; Pacific Biosciences of California Shares Spike Higher

Midway through trading Friday, the Dow traded down 0.39 percent to 25,280 while the NASDAQ declined 1.07 percent to 7,354.80.…

Why Pacific Biosciences of California Stock Is Skyrocketing Today

A $1.2 billion acquisition of the gene-sequencing company sends its shares into orbit....…

Illumina Buys Rival Pacific Biosciences In $1.2B Deal

Shares of Pacific Biosciences of California (NASDAQ: PACB), a developer of systems for gene sequencing, are soaring to a…

Pacific Biosciences rockets after DNA sequencing giant Illumina buys it for $1.2 billion

Investors sent shares in Pacific Biosciences of California (NASDAQ:PACB) soaring in premarket trade Friday after Illumina Inc (NASDAQ:ILMN), the company…

Pacific Biosciences of California Reports a Dismal Quarter -- and a Delightful Acquisition

A pending buyout by Illumina overshadows the gene-sequencing companys third-quarter performance....…

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Friday: ** Gene sequencing company Illumina Inc said on Thursday…

Illumina im Übernahmefieber - jetzt einsteigen-

Das Übernahmekarussell im Biotech-Sektor dreht sich weiter: Illumina will für 1,2 Milliarden Dollar den Rivalen Pacific Biosciences schlucken. Damit soll…

UPDATE 1-Illumina to buy rival Pacific Biosciences in $1.2 bln deal

Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an…

Pacific Biosciences surges on $1.2 billion takeover offer from DNA sequencing company Illumina (ILMN, PACB)

DNA sequencing company Illumina announced in a press release that it was acquiring Pacific Biosciences for approximately $1.2 billion. Illumina…

Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 bln deal

Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy Pacific Biosciences of California Inc in an all-cash deal…

DNA Sequencing Giant Illumina Will Buy Pacific Biosciences For $1.2 Billion - Exclusive CEO Interview

Illumina, the dominant maker of DNA sequencing machines, has agreed to purchase smaller rival Pacific Biosciences for $8 a share,…

Pacific Biosciences Introduces Enhancements to Sequel System

The latest enhancements in Pacific Biosciences??? (PACB) Sequel System represent strong improvement in terms of read length, throughput and accuracy…

Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel

Pacific Biosciences (PACB) sees a slew of developments in its coveted SMRT Sequel platform....…

Pacific Biosciences (PACB) Jumps: Stock Rises 5.4%

Pacific Biosciences (PACB) was a big mover last session, as the company saw its shares rise more than 5% on…

Pacific Biosciences Inching Closer To A Key Event

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is the Options Market Predicting a Spike in Pacific Biosciences (PACB) Stock-

Investors need to pay close attention to Pacific Biosciences (PACB) stock based on the movements in the options market lately....…

Why Pacific Biosciences Fell By 10.6% Earlier Today

The gene sequencing company plans to tap investors for more cash....…

Pacific Biosciences Sequel Sees Solid Q2, Competition Rife

Pacific Biosciences (PACB) gains from solid presence in Asia; competition likely to mar results....…

Pacific Biosciences (PACB) Loss In Line With Estimates in Q2

Strong performance in Product revenues boosts Pacific Biosciences (PACB) in Q2. Sequel order improves year over year....…

Pacific Biosciences of California Revenue Up Thanks to More System Installs

Shipments delayed in the first quarter were installed in the second quarter, boosting the gene-sequencing companys revenue....…

Pacific Biosciences of California (PACB) CEO Mike Hunkapiller on Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacific Biosciences of California (PACB) Reports Q2 Loss, Misses Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0.00% and -8.72%, respectively, for the quarter ended June 2018. Do…

Heres Why Pacific Biosciences Tumbled 10% Today

Investors are taking a cautious stance ahead of earnings next week and an ongoing trade spat with China....…

Whats in Store for Pacific Biosciences (PACB) Q2 Earnings-

Pacific Biosciences (PACB) flagship Sequel System is likely to drive Q2 results; competition is a headwind....…

Heres Why Pacific Biosciences of California, Inc. Rose 40.3% in June

The DNA sequencing leader announced upgrades to some of its core offerings....…

Researchers Of Newly Discovered European Cavefish Awarded Genome Sequencing Grant From Pacific Biosciences And GENEWIZ

MENLO PARK, Calif. and SOUTH PLAINFIELD, N.J., June 27, 2018 /PRNewswire/ -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), the…